Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study.
Ghusn W, Fansa S, Anazco D, Tama E, Nicolalde B, Gala K, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feres F, Hurtado MD, Acosta A.
Ghusn W, et al.
Int J Obes (Lond). 2024 May;48(5):662-667. doi: 10.1038/s41366-023-01456-5. Epub 2024 Feb 1.
Int J Obes (Lond). 2024.
PMID: 38302591